NCT02989298

Brief Summary

Brief Summary: The investigators are registering all PD patients at recruited hospitals and developing a PD database in China. Patients will be followed up every 3 months, and both baseline and follow-up information will be collected and input into the registration system. The patient survival, technical survival, peritonitis rate, longitudinal changes of residual renal function and peritoneum function, and quality of life for PD patients, etc, will be compared using the PD database.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10,000

participants targeted

Target at P75+ for all trials

Timeline
7mo left

Started Dec 2013

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress96%
Dec 2013Dec 2026

Study Start

First participant enrolled

December 1, 2013

Completed
2.9 years until next milestone

First Submitted

Initial submission to the registry

October 17, 2016

Completed
2 months until next milestone

First Posted

Study publicly available on registry

December 12, 2016

Completed
10 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

October 22, 2020

Status Verified

October 1, 2020

Enrollment Period

13 years

First QC Date

October 17, 2016

Last Update Submit

October 20, 2020

Conditions

ESRDDisorders Associated With Peritoneal Dialysis

Keywords

Peritoneal Dialysis (PD)Residual renal functionPeritoneum functionPeritonitis rateTechnical survivalPatient survival

Outcome Measures

Primary Outcomes (1)

  • Patient survival of PD patients

    Patient survival including all-cause and cardiovascular mortality.

    10 years

Secondary Outcomes (1)

  • Technical survival of PD patients

    10 years

Study Arms (1)

PD patients

End stage renal disease patients receiving peritoneal dialysis treatment

Other: No intervention

Interventions

No interventionOTHER

Registration of all PD patients in the First Affiliated Hospital of Sun Yat-sen University and other hospitals，which have signed the contract in China.

PD patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

ESRD patients receiving PD treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The First Affiliated Hospital, Sun Yat-sen University

Guangzhou, Guangdong, 510080, China

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

The serum, urine, DNA and peritoneum tissue will be collected.

MeSH Terms

Conditions

Kidney Failure, Chronic

Condition Hierarchy (Ancestors)

Renal Insufficiency, ChronicRenal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Xueqing Yu, M.D. & Ph.D.

    First Affiliated Hospital, Sun Yat-Sen University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Xueqing Yu, M.D. & Ph.D.

CONTACT

8620-87766335yuxq@mail.sysu.edu.cn

Xiao Yang, M.D. & Ph.D.

CONTACT

8620-87755766yangxsysu@126.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
10 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

October 17, 2016

First Posted

December 12, 2016

Study Start

December 1, 2013

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

October 22, 2020

Record last verified: 2020-10

Locations

CN(1)